Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
73.50
+1.39 (1.93%)
May 29, 2026, 4:00 PM EDT - Market closed
Spyre Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Maintains $95 | Buy | Maintains | $95 | +29.25% | May 18, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $103 | Buy | Maintains | $103 | +40.14% | May 17, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains $86 → $102 | Buy | Maintains | $86 → $102 | +38.78% | May 12, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $107 | Buy | Maintains | $107 | +45.58% | May 12, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $115 | Buy | Reiterates | $115 | +56.46% | May 7, 2026 |
| Citi | Citi | Buy Reiterates $64 → $97 | Buy | Reiterates | $64 → $97 | +31.97% | May 7, 2026 |
| Jefferies | Jefferies | Buy Maintains $85 → $95 | Buy | Maintains | $85 → $95 | +29.25% | May 6, 2026 |
| BTIG | BTIG | Buy Reiterates $98 | Buy | Reiterates | $98 | +33.33% | May 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.